← Leaderboards
Robert Michael Williams
University Of Calif-Los Alamos Nat Lab
$14,935,204
Attributed
$16,418,447
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$16,678,957 · 11
By mechanism
R01$14,564,143 · 5
R42$1,073,855 · 1
S10$771,793 · 3
R41$241,742 · 1
P41$27,424 · 1
Top collaborators
- David H Sherman5 shared
- Louis H Junker3 shared
- Betty Sue Pace3 shared
- Susan P Perrine1 shared
Others in their field
Top investigators on “Alkaloids”
- Phil S Baran · Harvard University$17,939,740
- Mohammad Movassaghi · Massachusetts Institute Of Technology$12,142,126
- Larry E. Overman · University Of California Irvine$10,943,107
- Paul D Kessler · Nabi Biopharmaceuticals$10,007,124
- Dale L Boger · Scripps Research Institute, The$8,395,075
- Stephen S Hecht · University Of Minnesota$8,249,211
Research focus
AlkaloidsBaseLaboratoriesProgramsComplexAnalogBiologicalBiological FactorsChemical SynthesisDrug Design /Synthesis /ProductionDesignFamilyUniversitiesTechnologyCyclizationEnzymesAntineoplastic AgentsCellsBiochemicalInvestigationPathway InteractionsAnabolismChemical AdditionGrant
Grant awards (62)
In Vivo Studies of a Novel HDAC Inhibitor for Treating Hemoglobin Disorders$550,046
R42 · FY2020 · HL
In Vivo Studies of a Novel HDAC Inhibitor for Treating Hemoglobin Disorders$24,589
R42 · FY2020 · HL
In Vivo Studies of a Novel HDAC Inhibitor for Treating Hemoglobin Disorders$499,220
R42 · FY2019 · HL
Total Synthesis and Biosynthesis of Bioactive Substances$256,101
R01 · FY2018 · CA · contact PI
Total Synthesis and Biosynthesis of Bioactive Substances$256,101
R01 · FY2017 · CA · contact PI
Novel HDAC Inhibitors for Treatment of Hemoglobinopathies$241,742
R41 · FY2017 · HL · contact PI
Total Synthesis and Biosynthesis of Bioactive Substances$256,101
R01 · FY2016 · CA · contact PI
Total Synthesis and Biosynthesis of Bioactive Substances$256,120
R01 · FY2015 · CA · contact PI
Multiple Myeloma and Cancer Therapies via Largazole Analogs$297,051
R01 · FY2014 · CA · contact PI
Total Synthesis and Biosynthesis of Bioactive Substances$268,515
R01 · FY2014 · CA · contact PI
Multiple Myeloma and Cancer Therapies via Largazole Analogs$287,684
R01 · FY2013 · CA · contact PI
Total Synthesis and Biosynthesis of Bioactive Substances$200,594
R01 · FY2013 · CA · contact PI
Tetrahydroisoquinoline Antitumor Drugs: Synthesis and Biosynthesis$306,196
R01 · FY2012 · CA · contact PI
Multiple Myeloma and Cancer Therapies via Largazole Analogs$305,856
R01 · FY2012 · CA · contact PI
Total Synthesis and Biosynthesis of Bioactive Substances$215,548
R01 · FY2012 · CA · contact PI
Tetrahydroisoquinoline Antitumor Drugs: Synthesis and Biosynthesis$308,676
R01 · FY2011 · CA · contact PI
Multiple Myeloma and Cancer Therapies via Largazole Analogs$305,666
R01 · FY2011 · CA · contact PI
Synthesis of Amino Acid-Containing Natural Products$241,345
R01 · FY2011 · GM · contact PI
Total Synthesis and Biosynthesis of Bioactive Substances$237,949
R01 · FY2011 · CA · contact PI
Multiple Myeloma and Cancer Therapies via Largazole Analogs$338,173
R01 · FY2010 · CA · contact PI
Tetrahydroisoquinoline Antitumor Drugs: Synthesis and Biosynthesis$324,001
R01 · FY2010 · CA · contact PI
Total Synthesis and Biosynthesis of Bioactive Substances$246,768
R01 · FY2010 · CA · contact PI
Synthesis of Amino Acid-Containing Natural Products$243,783
R01 · FY2010 · GM · contact PI
Tetrahydroisoquinoline Antitumor Drugs: Synthesis and Biosynthesis$328,947
R01 · FY2009 · CA · contact PI
Total Synthesis and Biosynthesis of Bioactive Substances$255,896
R01 · FY2009 · CA · contact PI
Synthesis of Amino Acid-Containing Natural Products$246,245
R01 · FY2009 · GM · contact PI
Synthesis of Et-743 Bioxalomycin and tetrazomine$299,791
R01 · FY2008 · CA · contact PI
Synthesis and Mechanism of DNA Cross-linking of FR900482$297,341
R01 · FY2008 · CA · contact PI
Synthesis of Amino Acid-Containing Natural Products$290,825
R01 · FY2008 · GM · contact PI
400 MHz NMR Spectrometer for CSU Chemistry Facility$250,773
S10 · FY2008 · RR · contact PI
Total Synthesis and Biosynthesis of Bioactive Substances$203,525
R01 · FY2008 · CA · contact PI
Synthesis of Et-743 Bioxalomycin and tetrazomine$299,791
R01 · FY2007 · CA · contact PI
Synthesis and Mechanism of DNA Cross-linking of FR900482$297,662
R01 · FY2007 · CA · contact PI
Synthesis of Amino Acid-Containing Natural Products$215,368
R01 · FY2007 · GM · contact PI
Total Synthesis and Biosynthesis of Bioactive Substances$203,525
R01 · FY2007 · CA · contact PI
Synthesis of Et-743 Bioxalomycin and tetrazomine$308,745
R01 · FY2006 · CA · contact PI
Synthesis and Mechanism of DNA Cross-linking of FR900482$306,883
R01 · FY2006 · CA · contact PI
LC/MDS TOF SPECTROMETER FOR INSTRUMENT FACILITY AT CSU: CHEMISTRY$260,510
S10 · FY2006 · RR · contact PI
LC/MDS TOF Spectrometer for Instrument Facility at CSU$260,510
S10 · FY2006 · RR · contact PI
Synthesis of Amino Acid-Containing Natural Products$221,800
R01 · FY2006 · GM · contact PI
Total Synthesis and Biosynthesis of Bioactive Substances$209,603
R01 · FY2006 · CA · contact PI
Synthesis of Et-743 Bioxalomycin and tetrazomine$316,175
R01 · FY2005 · CA
Synthesis and Mechanism of DNA Cross-linking of FR900482$314,607
R01 · FY2005 · CA
Synthesis of Amino Acid-Containing Natural Products$227,137
R01 · FY2005 · GM
Total Synthesis and Biosynthesis of Bioactive Substances$224,209
R01 · FY2005 · CA
Synthesis of Et-743 Bioxalomycin and tetrazomine$316,175
R01 · FY2004 · CA
Synthesis and Mechanism of DNA Cross-linking of FR900482$314,946
R01 · FY2004 · CA
Synthesis of Amino Acid-Containing Natural Products$261,899
R01 · FY2004 · GM
TOTAL SYNTHESIS AND BIOSYNTHESIS OF BIOACTIVE SUBSTANCES$214,419
R01 · FY2004 · CA
TOTAL SYNTHESEIS OF BIOXALOMYCIN, ET743 AND TETRAZOMINE$304,277
R01 · FY2003 · CA
SYNTHESIS AND MECHANISM OF DNA CROSSLINKING OF FR900482$291,145
R01 · FY2003 · CA
TOTAL SYNTHESIS AND BIOSYNTHESIS OF BIOACTIVE SUBSTANCES$214,419
R01 · FY2003 · CA
TOTAL SYNTHESEIS OF BIOXALOMYCIN, ET743 AND TETRAZOMINE$296,079
R01 · FY2002 · CA
SYNTHESIS AND MECHANISM OF DNA CROSSLINKING OF FR900482$291,145
R01 · FY2002 · CA
TOTAL SYNTHESIS AND BIOSYNTHESIS OF BIOACTIVE SUBSTANCES$214,419
R01 · FY2002 · CA
SYNTHESIS AND MECHANISM OF DNA CROSSLINKING OF FR900482$291,145
R01 · FY2001 · CA
TOTAL SYNTHESEIS OF BIOXALOMYCIN, ET743 AND TETRAZOMINE$288,117
R01 · FY2001 · CA
TOTAL SYNTHESIS AND BIOSYNTHESIS OF BIOACTIVE SUBSTANCES$239,419
R01 · FY2001 · CA
SYNTHESIS AND MECHANISM OF DNA CROSSLINKING OF FR900482$307,570
R01 · FY2000 · CA
TOTAL SYNTHESEIS OF BIOXALOMYCIN, ET743 AND TETRAZOMINE$306,490
R01 · FY2000 · CA
TOTAL SYNTHESIS AND BIOSYNTHESIS OF BIOACTIVE SUBSTANCES$192,176
R01 · FY2000 · CA
BIOSYNTHESIS OF PARAHERQUAMIDES &BREVIANAMIDES$27,424
P41 · FY2000 · RR